Six-year-old girl dies after experimental brain-directed CRISPR therapy in China

A six-year-old girl in China died after receiving an experimental, brain-directed CRISPR gene-editing therapy, as reported in detail by the journal Science. The case has prompted serious questions about ethical standards and regulatory oversight of clinical trials in China. The tragedy reignites debate about acceptable risk thresholds in experimental medicine.